VA Puget Sound Health Care System

Dr. James E. Blevins of the VA Puget Sound Health Care System completed the study with colleagues from Seattle Children’s Research Institute; the University of Washington; Harvard Medical School; and OXT Therapeutics, Inc. The research focused on ASK1476, a human-made peptide with a structure similar to that of oxytocin.

I’m involved in prostate cancer basic research and new drug development. Prostate cancer is the most common non-skin cancer in Veterans. About 35,000 Veterans with prostate cancer receive treatment in the VA system.

VA researchers are studying the safety and effectiveness of 3D-printed nasal swabs, in case of another urgent nationwide need to test patients for COVID-19 or other infectious diseases.

The research team included investigators from the VA Palo Alto Health Care System, VA Puget Sound Health Care System, VA Tennessee Valley Healthcare System, and several other research institutions, including Yale University.

Hear the latest on treating prostate cancer. Check out a Feb. 24 lecture, online or in person at VA headquarters, on precision oncology for Veterans.

A partnership between VA and the Prostate Cancer Foundation is speeding the development of treatments and cures for Veterans with aggressive—or metastatic—prostate cancer through precision oncology.